BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Byun KH, Kim SW. Is stem cell-based therapy going on or out for cardiac disease? Korean Circ J 2009;39:87-92. [PMID: 19949592 DOI: 10.4070/kcj.2009.39.3.87] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Kim MH, Guo L, Kim HS, Kim SW. Characteristics of circulating CD31(+) cells from patients with coronary artery disease. J Cell Mol Med 2014;18:2321-30. [PMID: 25267411 DOI: 10.1111/jcmm.12370] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
2 Kim SW, Lee DW, Yu LH, Zhang HZ, Kim CE, Kim JM, Park TH, Cha KS, Seo SY, Roh MS. Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model. Cardiovasc Res. 2012;95:495-506. [PMID: 22886775 DOI: 10.1093/cvr/cvs224] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 5.6] [Reference Citation Analysis]
3 Hur J, Yang JM, Choi JI, Yun JY, Jang JH, Kim J, Kim JY, Oh IY, Yoon CH, Cho HJ, Park YB, Kim HS. New method to differentiate human peripheral blood monocytes into insulin producing cells: Human hematosphere culture. Biochem Biophys Res Commun 2012;418:765-9. [PMID: 22310720 DOI: 10.1016/j.bbrc.2012.01.096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
4 Jin E, Kim JM, Kim SW. Priming of mononuclear cells with a combination of growth factors enhances wound healing via high angiogenic and engraftment capabilities. J Cell Mol Med 2013;17:1644-51. [PMID: 24118840 DOI: 10.1111/jcmm.12152] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
5 Shim TJ, Bae JW, Kim YJ, Kim DJ, Hwang KK, Kim DW, Cho MC. Cardioprotective effects of 3-phosphoinositide-dependent protein kinase-1 on hypoxic injury in cultured neonatal rat cardiomyocytes and myocardium in a rat myocardial infarct model. Biosci Biotechnol Biochem 2012;76:101-7. [PMID: 22232248 DOI: 10.1271/bbb.110562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
6 Park JH, Yoon JY, Ko SM, Jin SA, Kim JH, Cho CH, Kim JM, Lee JH, Choi SW, Seong IW, Jeong JO. Endothelial progenitor cell transplantation decreases lymphangiogenesis and adverse myocardial remodeling in a mouse model of acute myocardial infarction. Exp Mol Med 2011;43:479-85. [PMID: 21694495 DOI: 10.3858/emm.2011.43.8.054] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
7 Hong SJ, Hou D, Brinton TJ, Johnstone B, Feng D, Rogers P, Fearon WF, Yock P, March KL. Intracoronary and retrograde coronary venous myocardial delivery of adipose-derived stem cells in swine infarction lead to transient myocardial trapping with predominant pulmonary redistribution. Catheter Cardiovasc Interv. 2014;83:E17-E25. [PMID: 22972685 DOI: 10.1002/ccd.24659] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
8 Kim S, Zhang H, Kim C, Kim J, Kim MH. Amniotic mesenchymal stem cells with robust chemotactic properties are effective in the treatment of a myocardial infarction model. International Journal of Cardiology 2013;168:1062-9. [DOI: 10.1016/j.ijcard.2012.11.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
9 Li Y, Guo L, Ahn HS, Kim MH, Kim SW. Amniotic mesenchymal stem cells display neurovascular tropism and aid in the recovery of injured peripheral nerves. J Cell Mol Med 2014;18:1028-34. [PMID: 24708439 DOI: 10.1111/jcmm.12249] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
10 Santos DSD, Goldenberg RCDS. Doxorubicin-Induced Cardiotoxicity: From Mechanisms to Development of Efficient Therapy. In: Tan W, editor. Cardiotoxicity. InTech; 2018. [DOI: 10.5772/intechopen.79588] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
11 Hur J, Choi JI, Yun JY, Yoon CH, Jang JH, Im SG, Ko SB, Kang JA, Park J, Lee SE, Kim JY, Yang HM, Park YB, Kim HS. Highly angiogenic CXCR4(+)CD31(+) monocyte subset derived from 3D culture of human peripheral blood. Biomaterials 2013;34:1929-41. [PMID: 23267826 DOI: 10.1016/j.biomaterials.2012.11.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
12 Ghafarzadeh M, Namdari M, Eatemadi A. Stem cell therapies for congenital heart disease. Biomed Pharmacother 2016;84:1163-71. [PMID: 27780147 DOI: 10.1016/j.biopha.2016.10.055] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]